This is MS Talks 2.0.Let's discuss facts. We have a very interesting topic for you today.We're covering listening to your gut.Over the years, there's been lots of information released about the gut and its influence on your wellbeing. It seems that changes in the gut bacteria or microbiome have a direct impact on the immune system and may even play a part in ... Show More
Apr 2023
MS Talks 2.0: Finding Acceptance
In this episode, Muna Al Harbi, MS patient advocate, member of the National MS Society, and Transformational and Personal Growth coach joins the show to share her tips for coping with an MS diagnosis and eventually finding acceptance.Muna has documented her journey throughout MS ... Show More
9m 48s
Mar 2023
MS Talks 2.0: A Network of Support
In this episode of MS Talks 2.0, we look at the importance of building a support network for patients, and in turn, how friends and family of MS patients can provide support.To give more clarity on how to approach these delicate situations, Professor. Anu Jacob, DM, FRCP, is the ... Show More
17m 15s
Mar 2023
MS Talks 2.0: Chasing A Cure For MS Using Stem Cells
This is MS Talks 2.0, Let’s Discuss Facts,a series brought to you by Novartis. Multiple sclerosis is an incurable disease.And if you receive a diagnosis, there can be a tendency to seek different approaches such as stem cell therapy, in search of an elusive cure.In this episode, ... Show More
11m 21s
Jan 2022
Why the Gut is the Key to Health
We’re joined by Dr. Emeran Mayer; a professor, gastroenterologist, scientist, and author about the latest research on the gut microbiome, the connection between the gut microbiome and the immune system, and how we can improve the health of our gut to support our overall health.
W ... Show More
45m 28s
Mar 2024
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Dr. Shuvro Roy talks with Dr. Annette Langer-Gould about the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Read the related article in Neurology: Neuroimmunology ... Show More
24m 12s
Mar 2024
Multiple Sclerosis, Rituximab, Hypogammaglobulinemia and Risk of Infections
Dr. Shuvro Roy and Dr. Annette Langer-Gould discuss the effective dose of rituximab and other B-cell depleting therapies in patients with multiple sclerosis, as well as important comorbidities to prevent infection risks. Show reference: https://www.neurology.org/doi/10.1212/NXI.0 ... Show More
4m 4s